Verastem And Adial Pharmaceuticals On The List Of Winners And Losers Of Tuesday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Verastem, Gevo, and Vicor Corporation.

Rank Financial Asset Price Change Updated (EST)
1 Verastem (VSTM) 1.01 125.55% 2023-05-29 21:08:08
2 Gevo (GEVO) 1.35 21.17% 2023-05-30 14:25:16
3 Vicor Corporation (VICR) 60.15 11.39% 2023-05-29 19:13:07
4 Achieve Life Sciences (ACHV) 6.28 11.15% 2023-05-30 03:48:08
5 Riot Blockchain (RIOT) 12.10 10.85% 2023-05-30 14:46:53
6 Wayfair (W) 39.81 9.29% 2023-05-30 13:47:18
7 MicroVision (MVIS) 4.42 9.14% 2023-05-30 14:57:13
8 Palantir (PLTR) 14.88 9.01% 2023-05-30 13:48:10
9 Cloudflare (NET) 66.32 8.47% 2023-05-30 13:48:56
10 ACM Research (ACMR) 10.71 8.4% 2023-05-30 04:17:07

The three biggest losers today are Adial Pharmaceuticals, Applied UV, and Aspen Group.

Rank Financial Asset Price Change Updated (EST)
1 Adial Pharmaceuticals (ADILW) 0.01 -41.18% 2023-05-30 04:42:07
2 Applied UV (AUVI) 0.38 -32.52% 2023-05-30 15:47:09
3 Aspen Group (ASPU) 0.14 -11.18% 2023-05-30 09:30:04
4 Niu Technologies (NIU) 3.63 -8.56% 2023-05-30 14:46:22
5 American Public Education (APEI) 5.21 -8.11% 2023-05-30 14:53:23
6 Nautilus (NLS) 1.26 -8.03% 2023-05-30 13:43:47
7 Annexon (ANNX) 2.62 -7.89% 2023-05-30 11:13:07
8 Weibo (WB) 14.15 -7.42% 2023-05-30 14:59:20
9 Aquestive Therapeutics (AQST) 2.08 -7.37% 2023-05-30 13:14:07
10 Antero Resources (AR) 20.32 -6.25% 2023-05-30 13:38:04

Winners today

1. Verastem (VSTM) – 125.55%

Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing medicines to enhance the life of cancer patients. Its product in development include VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibitor that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The company also engages in developing RAMP 201, an adaptive two-part multicenter open label trial to evaluate the efficacy and safety of VS-6766 and in combination with defactinib, an oral small molecule inhibitor of focal adhesion kinase (FAK) in patients with recurrent low grade serous ovarian cancer; and RAMP 202, which is in Phase 2 trial to evaluate the safety of VS-6766 in combination with defactinib in patients with KRAS mutant non-small cell lung cancer following treatment with a platinum-based regimen and immune checkpoint inhibitor. Verastem, Inc. has license agreements with Chugai Pharmaceutical Co., Ltd. for the development, commercialization, and manufacture of products containing VS-6766; and Pfizer Inc. to research, develop, manufacture, and commercialize products containing Pfizer's inhibitors of FAK for therapeutic, diagnostic and prophylactic uses in humans. The company was incorporated in 2010 and is headquartered in Needham, Massachusetts.

NASDAQ ended the session with Verastem rising 125.55% to $1.01 on Tuesday while NASDAQ jumped 0.32% to $13,017.43.

Earnings Per Share

As for profitability, Verastem has a trailing twelve months EPS of $-0.83.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -114.31%.

More news about Verastem.

2. Gevo (GEVO) – 21.17%

Gevo, Inc. operates as a renewable fuels company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company offers renewable gasoline and diesel, isooctane, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.

NASDAQ ended the session with Gevo jumping 21.17% to $1.35 on Tuesday while NASDAQ rose 0.32% to $13,017.43.

Earnings Per Share

As for profitability, Gevo has a trailing twelve months EPS of $-0.43.

Volume

Today’s last reported volume for Gevo is 11794900 which is 97.74% above its average volume of 5964660.

Moving Average

Gevo’s value is under its 50-day moving average of $1.40 and way below its 200-day moving average of $2.10.

More news about Gevo.

3. Vicor Corporation (VICR) – 11.39%

Vicor Corporation, together with its subsidiaries, designs, develops, manufactures, and markets modular power components and power systems for converting electrical power in the United States, Europe, the Asia Pacific, and internationally. The company offers a range of brick-format DC-DC converters; complementary components; and input and output voltage, and output power products, as well as electrical and mechanical accessories. It also provides custom power systems solutions. The company serves independent manufacturers of electronic devices, original equipment manufacturers, and their contract manufacturers in the aerospace and aviation, defense electronics, industrial automation and equipment, instrumentation, test equipment, solid state lighting, telecommunications and networking infrastructure, and vehicles and transportation markets. Vicor Corporation was founded in 1981 and is headquartered in Andover, Massachusetts.

NASDAQ ended the session with Vicor Corporation rising 11.39% to $60.15 on Tuesday, after two successive sessions in a row of gains. NASDAQ rose 0.32% to $13,017.43, after two successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Vicor Corporation has a trailing twelve months EPS of $0.79.

PE Ratio

Vicor Corporation has a trailing twelve months price to earnings ratio of 76.14. Meaning, the purchaser of the share is investing $76.14 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.94%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Vicor Corporation’s EBITDA is 4.03.

More news about Vicor Corporation.

4. Achieve Life Sciences (ACHV) – 11.15%

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

NASDAQ ended the session with Achieve Life Sciences rising 11.15% to $6.28 on Tuesday while NASDAQ jumped 0.32% to $13,017.43.

Earnings Per Share

As for profitability, Achieve Life Sciences has a trailing twelve months EPS of $-4.11.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -400.16%.

More news about Achieve Life Sciences .

5. Riot Blockchain (RIOT) – 10.85%

Riot Platforms, Inc., together with its subsidiaries, operates as a bitcoin mining company in North America. It operates through Bitcoin Mining, Data Center Hosting, and Engineering segments. The company also provides co-location services for institutional-scale bitcoin mining companies; and critical infrastructure and workforce for institutional-scale miners to deploy and operate their miners. In addition, it engages in the design and manufacturing of power distribution equipment and custom engineered electrical products; electricity distribution product design, manufacture, and installation services primarily focused on large-scale commercial and governmental customers, as well as a range of markets, including data center, power generation, utility, water, industrial, and alternative energy; operation of data centers; and maintenance/management of computing capacity. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is based in Castle Rock, Colorado.

NASDAQ ended the session with Riot Blockchain jumping 10.85% to $12.10 on Tuesday while NASDAQ rose 0.32% to $13,017.43.

Earnings Per Share

As for profitability, Riot Blockchain has a trailing twelve months EPS of $-4.23.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.54%.

More news about Riot Blockchain.

6. Wayfair (W) – 9.29%

Wayfair Inc. engages in the e-commerce business in the United States and internationally. The company provides approximately fourty million products for the home sector under various brands. It offers online selections of furniture, décor, housewares, and home improvement products through its sites, including Wayfair, Joss & Main, AllModern, Birch Lane, Perigold, and Wayfair Professional. The company was founded in 2002 and is headquartered in Boston, Massachusetts.

NYSE ended the session with Wayfair rising 9.29% to $39.81 on Tuesday while NYSE slid 0.56% to $14,994.64.

Earnings Per Share

As for profitability, Wayfair has a trailing twelve months EPS of $-13.21.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Wayfair’s stock is considered to be oversold (<=20).

Volatility

Wayfair’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.16%, a negative 0.13%, and a positive 3.50%.

Wayfair’s highest amplitude of average volatility was 1.81% (last week), 4.80% (last month), and 3.50% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 59.8% and 63%, respectively.

Moving Average

Wayfair’s value is way higher than its 50-day moving average of $34.79 and below its 200-day moving average of $41.61.

More news about Wayfair.

7. MicroVision (MVIS) – 9.14%

MicroVision, Inc. develops and sells lidar sensors used in automotive safety and autonomous driving applications. Its laser beam scanning technology is based on micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company also develops micro-display concepts and designs for head-mounted augmented reality (AR) headsets, as well as 1440i MEMS module supporting AR headsets; interactive display solutions for the smart speakers market; and Consumer Lidar used in smart home systems. In addition, it develops 1st Generation LRL module. The company sells its products primarily to original equipment manufacturers and original design manufacturers. MicroVision, Inc. was founded in 1993 and is headquartered in Redmond, Washington.

NASDAQ ended the session with MicroVision rising 9.14% to $4.42 on Tuesday while NASDAQ rose 0.32% to $13,017.43.

Earnings Per Share

As for profitability, MicroVision has a trailing twelve months EPS of $-0.38.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -62.05%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MicroVision’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth grew by 123.4%, now sitting on 1.1M for the twelve trailing months.

Yearly Top and Bottom Value

MicroVision’s stock is valued at $4.42 at 17:32 EST, way below its 52-week high of $5.96 and way higher than its 52-week low of $1.82.

More news about MicroVision.

8. Palantir (PLTR) – 9.01%

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community in the United States to assist in counterterrorism investigations and operations. The company provides Palantir Gotham, a software platform which enables users to identify patterns hidden deep within datasets, ranging from signals intelligence sources to reports from confidential informants, as well as facilitates the handoff between analysts and operational users, helping operators plan and execute real-world responses to threats that have been identified within the platform. It also offers Palantir Foundry, a platform that transforms the ways organizations operate by creating a central operating system for their data; and allows individual users to integrate and analyze the data they need in one place. In addition, it provides Palantir Apollo, a software that enables customers to deploy their own software virtually in any environment. Palantir Technologies Inc. was incorporated in 2003 and is based in Denver, Colorado.

NYSE ended the session with Palantir jumping 9.01% to $14.88 on Tuesday, after four sequential sessions in a row of gains. NYSE dropped 0.56% to $14,994.64, following the last session’s upward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Palantir has a trailing twelve months EPS of $-0.13.

Volatility

Palantir’s last week, last month’s, and last quarter’s current intraday variation average was 2.65%, 2.91%, and 3.04%.

Palantir’s highest amplitude of average volatility was 4.88% (last week), 4.26% (last month), and 3.04% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Palantir’s stock is considered to be oversold (<=20).

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 600% and 400%, respectively.

More news about Palantir.

9. Cloudflare (NET) – 8.47%

CloudFlare, Inc. operates as a cloud services provider that delivers a range of services to businesses worldwide. The company provides an integrated cloud-based security solution to secure a range of combination of platforms, including public cloud, private cloud, on-premise, software-as-a-service applications, and IoT devices; and website and application security products comprising web application firewall, bot management, distributed denial of service, API gateways, SSL/TLS encryption, secure origin connection, and rate limiting products. It also offers website and application performance solutions, including content delivery, load balancing, DNS, agro smart routing, video stream delivery, content optimization, virtual backbone, always online, and cloudflare waiting room and registrar; and network services, which deliver network connectivity, security, and performance to customers as a service, including WAN, WARP, magic transit, magic firewall, cloudflare network interconnect, and spectrum. In addition, the company provides zero trust services, such as cloudflare access, cloudflare gateway, remote browser isolation, cloud access security broker, cloudflare area 1 email security, and data loss prevention products that protect, inspect, and privilege data. Further, it provides developer-based solutions consisting of cloudflare workers, pages, stream, and images, as well as Cloudflare Data Localization suite, a tool that set rules and controls at the network edge; durable objects and R2 object storage products; Consumer DNS Resolver, a consumer app to browse the Internet; and consumer VPN for consumers to secure and accelerate traffic on mobile devices. The company serves customers in the technology, healthcare, financial services, consumer and retail, and non-profit industries, as well as government. CloudFlare, Inc. was incorporated in 2009 and is headquartered in San Francisco, California.

NYSE ended the session with Cloudflare jumping 8.47% to $66.32 on Tuesday while NYSE dropped 0.56% to $14,994.64.

Earnings Per Share

As for profitability, Cloudflare has a trailing twelve months EPS of $-0.61.

Volume

Today’s last reported volume for Cloudflare is 6033190 which is 12.24% above its average volume of 5375180.

More news about Cloudflare.

10. ACM Research (ACMR) – 8.4%

ACM Research, Inc., together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. It offers space alternated phase shift technology for flat and patterned wafer surfaces, which employs alternating phases of megasonic waves to deliver megasonic energy in a uniform manner on a microscopic level; timely energized bubble oscillation technology for patterned wafer surfaces at advanced process nodes, which provides cleaning for 2D and 3D patterned wafers with fine feature sizes; Tahoe technology for delivering cleaning performance using less sulfuric acid and hydrogen peroxide; and electro-chemical plating technology for advanced metal plating. The company markets and sells its products under the Ultra C brand name through direct sales force and third-party representatives. ACM Research, Inc. was incorporated in 1998 and is headquartered in Fremont, California.

NASDAQ ended the session with ACM Research rising 8.4% to $10.71 on Tuesday, after two sequential sessions in a row of gains. NASDAQ jumped 0.32% to $13,017.43, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, ACM Research has a trailing twelve months EPS of $0.93.

PE Ratio

ACM Research has a trailing twelve months price to earnings ratio of 11.52. Meaning, the purchaser of the share is investing $11.52 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.16%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 45.5% and a negative 37.8%, respectively.

More news about ACM Research.

Losers Today

1. Adial Pharmaceuticals (ADILW) – -41.18%

NASDAQ ended the session with Adial Pharmaceuticals dropping 41.18% to $0.01 on Tuesday while NASDAQ rose 0.32% to $13,017.43.

More news about Adial Pharmaceuticals.

2. Applied UV (AUVI) – -32.52%

Applied UV, Inc. designs, develops, and markets air purification and infection control products in the healthcare, hospitality, commercial, municipal, and residential markets in the United States. The company offers solutions and products in air purification under the Airocide brand and label and disinfection of hard surfaces under the Lumicide brand. It also manufactures and supplies fine decorative framed mirrors, framed art, and vanities. The company is based in Mount Vernon, New York.

NASDAQ ended the session with Applied UV dropping 32.52% to $0.38 on Tuesday while NASDAQ rose 0.32% to $13,017.43.

Earnings Per Share

As for profitability, Applied UV has a trailing twelve months EPS of $-1.3.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -70.02%.

Sales Growth

Applied UV’s sales growth is 93.3% for the ongoing quarter and 86.2% for the next.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Applied UV’s EBITDA is 0.82.

More news about Applied UV.

3. Aspen Group (ASPU) – -11.18%

Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.

NASDAQ ended the session with Aspen Group falling 11.18% to $0.14 on Tuesday while NASDAQ jumped 0.32% to $13,017.43.

Earnings Per Share

As for profitability, Aspen Group has a trailing twelve months EPS of $-0.38.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Sales Growth

Aspen Group’s sales growth is negative 24% for the present quarter and negative 29.3% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Aspen Group’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

Aspen Group’s stock is valued at $0.14 at 17:32 EST, way under its 52-week high of $1.34 and way higher than its 52-week low of $0.03.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Aspen Group’s EBITDA is 342.31.

More news about Aspen Group.

4. Niu Technologies (NIU) – -8.56%

Niu Technologies designs, manufactures, and sells smart electric scooters in the People's Republic of China. The company offers RQi, NQi, MQi, SQi, UQi, and Gova series electric scooters and motorcycles; KQi series one kick-scooters; BQi series e-bikes; and Niu Aero Sports Bicycles. It also provides accessories and spare parts under the NIU brand name comprising scooter accessories, such as raincoats, gloves, knee pads, storage baskets and tail boxes, smart phone holders, backrests, and locks; lifestyle accessories, which includes T-shirts, coats, sweaters and hoodies, jeans, hats, bags, jewelry, notebook, badges, key chain, and mugs; and performance upgrade components that comprises of upgraded wheels, shock absorbers, brake calipers, and carbon fiber body panels. In addition, the company, through its NIU app, offers online repair request, DIY repairs, service station locator, theft reporting, smart check, and smart services, as well as NIU cover, which provides insurance services. Niu Technologies sells and services its products through city partners and franchised stores, distributors, and third-party e-commerce platforms and the company's online store. The company was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.

NASDAQ ended the session with Niu Technologies falling 8.56% to $3.63 on Tuesday, after four sequential sessions in a row of losses. NASDAQ jumped 0.32% to $13,017.43, after two successive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Niu Technologies has a trailing twelve months EPS of $-0.14.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.41%.

Yearly Top and Bottom Value

Niu Technologies’s stock is valued at $3.63 at 17:32 EST, way under its 52-week high of $9.60 and way above its 52-week low of $2.57.

Volatility

Niu Technologies’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.52%, a positive 0.33%, and a positive 2.88%.

Niu Technologies’s highest amplitude of average volatility was 3.52% (last week), 3.74% (last month), and 2.88% (last quarter).

More news about Niu Technologies.

5. American Public Education (APEI) – -8.11%

American Public Education, Inc., together with its subsidiaries, provides online and campus-based postsecondary education and career learning. It operates through three segments: American Public University System, Rasmussen University, and Hondros College of Nursing. The company offers 136 degree programs and 115 certificate programs in various fields of study, including nursing, public health, public administration, and business administration. It also provides nursing-and health sciences-focused postsecondary education, diploma in practical nursing, and an associate degree in nursing. The company was incorporated in 1991 and is headquartered in Charles Town, West Virginia.

NASDAQ ended the session with American Public Education falling 8.11% to $5.21 on Tuesday, after two sequential sessions in a row of losses. NASDAQ jumped 0.32% to $13,017.43, after two consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, American Public Education has a trailing twelve months EPS of $-6.12.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -32.91%.

Sales Growth

American Public Education’s sales growth is negative 2.3% for the present quarter and 0.3% for the next.

Revenue Growth

Year-on-year quarterly revenue growth declined by 3.3%, now sitting on 601.27M for the twelve trailing months.

More news about American Public Education.

6. Nautilus (NLS) – -8.03%

Nautilus, Inc., a fitness solutions company, designs, develops, sources, and markets cardio and strength fitness products, and related accessories for consumer and commercial use in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company operates in two segments, Direct and Retail. It offers specialized cardio products, treadmills, ellipticals, bike products, home gyms, dumbbells, barbells, and kettlebells primarily under the Nautilus, Bowflex, Octane Fitness, and Schwinn brands, as well as fitness digital platform under the JRNY brand. In addition, it engages in licensing its brands and intellectual properties. The company offers its products directly to consumers through television advertising, social media, websites, and catalogs; and through a network of retail companies consisting of sporting goods stores, online retailers, electronics stores, furniture stores, and large-format and warehouse stores, as well as specialty retailers and independent bike dealers. Nautilus, Inc. was founded in 1986 and is headquartered in Vancouver, Washington.

NYSE ended the session with Nautilus dropping 8.03% to $1.26 on Tuesday, following the last session’s upward trend. NYSE fell 0.56% to $14,994.64, following the last session’s upward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Nautilus has a trailing twelve months EPS of $-3.66.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -95.4%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 42.9%, now sitting on 286.77M for the twelve trailing months.

More news about Nautilus.

7. Annexon (ANNX) – -7.89%

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune and neurodegenerative diseases. It focuses on the treatment of body, brain, and eye disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, which has completed Phase 1b clinical trials to treat patients with guillain- barré syndrome; and ANX007, which has completed Phase 1b clinical trials to treat patients with glaucoma. The company's candidates also comprise ANX005 that has completed preclinical trials to treat patients with warm autoimmune hemolytic anemia, Huntington's disease, and amyotrophic lateral sclerosis; ANX007, which has completed preclinical trials for the treatment of geographic atrophy; and ANX009 that has completed preclinical trials for the treatment of systemic autoimmune diseases. The company was founded in 2011 and is headquartered in South San Francisco, California.

NASDAQ ended the session with Annexon dropping 7.89% to $2.62 on Tuesday while NASDAQ rose 0.32% to $13,017.43.

Earnings Per Share

As for profitability, Annexon has a trailing twelve months EPS of $-2.99.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -69.92%.

Volume

Today’s last reported volume for Annexon is 1402910 which is 85.27% above its average volume of 757187.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is 43.7% and a drop 9.8% for the next.

Yearly Top and Bottom Value

Annexon’s stock is valued at $2.62 at 17:32 EST, way below its 52-week high of $7.65 and way higher than its 52-week low of $2.07.

More news about Annexon.

8. Weibo (WB) – -7.42%

Weibo Corporation, through its subsidiaries, operates as a social media platform for people to create, distribute, and discover content in the People's Republic of China. It operates in two segments, Advertising and Marketing Services; and Value-Added Services. The company offers discovery products to help users discover content on its platform; self-expression products that enable its users to express themselves on its platform; and social products to promote social interaction between users on its platform. It also provides advertising and marketing solutions, such as social display advertisements; and promoted marketing offerings, such as Fans Headline and Weibo Express promoted feeds, as well as promoted trends and search products that appear alongside user's trends discovery and search behaviors. In addition, the company offers products, such as trends, search, video/live streaming, and editing tools; content customization, copyright contents pooling, and user interaction development; and search list recommendation, trends list recommendation, and Weibo app opening advertisements. Further, it provides back-end management, traffic support, and product solutions to MCNs, unions, and e-commerce partners; open application platform for other app developers that allows users to log into third-party applications with their Weibo account for sharing third-party content on its platform; and Weibo Wallet, a product that enables platform partners to conduct interest generation activities on Weibo, such as handing out red envelops and coupons. The company was formerly known as T.CN Corporation and changed its name to Weibo Corporation in 2012. The company was founded in 2009 and is headquartered in Beijing, China. Weibo Corporation operates as a subsidiary of Sina Corporation.

NASDAQ ended the session with Weibo sliding 7.42% to $14.15 on Tuesday while NASDAQ rose 0.32% to $13,017.43.

Earnings Per Share

As for profitability, Weibo has a trailing twelve months EPS of $0.34.

PE Ratio

Weibo has a trailing twelve months price to earnings ratio of 41.63. Meaning, the purchaser of the share is investing $41.63 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.7%.

Moving Average

Weibo’s worth is way under its 50-day moving average of $17.20 and way under its 200-day moving average of $17.72.

More news about Weibo.

9. Aquestive Therapeutics (AQST) – -7.37%

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; and Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation of epinephrine for the treatment of anaphylaxis; and AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.

NASDAQ ended the session with Aquestive Therapeutics dropping 7.37% to $2.08 on Tuesday, following the last session’s upward trend. NASDAQ rose 0.32% to $13,017.43, after two sequential sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Aquestive Therapeutics has a trailing twelve months EPS of $-0.7.

More news about Aquestive Therapeutics.

10. Antero Resources (AR) – -6.25%

Antero Resources Corporation, an independent oil and natural gas company, engages in the development, production, exploration, and acquisition of natural gas, natural gas liquids (NGLs), and oil properties in the United States. It operates through three segments: Exploration, Development and Production of Natural Gas, NGLs and Oil; Marketing and Utilization of Excess Firm Transportation Capacity; and Midstream Services Through Our Equity Method Investment in Antero Midstream. As of December 31, 2022, the company had approximately 504,000 net acres in the Appalachian Basin; and 174,000 net acres in the Upper Devonian Shale. It also owned and operated 620 miles of gas gathering pipelines in the Appalachian Basin; and 34 compressor stations. The company was formerly known as Antero Resources Appalachian Corporation and changed its name to Antero Resources Corporation in June 2013. Antero Resources Corporation was incorporated in 2002 and is headquartered in Denver, Colorado.

NYSE ended the session with Antero Resources sliding 6.25% to $20.32 on Tuesday while NYSE dropped 0.56% to $14,994.64.

Earnings Per Share

As for profitability, Antero Resources has a trailing twelve months EPS of $6.7.

PE Ratio

Antero Resources has a trailing twelve months price to earnings ratio of 3.03. Meaning, the purchaser of the share is investing $3.03 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 38.17%.

More news about Antero Resources.

Stay up to date with our winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *